Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Supernus Pharmaceuticals, Inc. has announced its agreement to merge with Indivior Pharmaceuticals, creating a diversified CNS biopharmaceutical company. This merger aims to enhance their operational scale and growth potential. The combined entity will be well-positioned to pursue additional business opportunities in the CNS market.
Company Information
Company
Supernus Pharmaceuticals
Location
Rockville, Maryland, United States
About
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The company has a significant experience in CNS and has successfully introduced more than eight widely recognized products in this therapeutic category. Their recent advancement includes ONAPGO, a subcutaneous apomorphine infusion device for treating motor fluctuations associated with Parkinson’s disease. Supernus is committed to developing novel alternatives for managing neurological conditions.
RockvilleBiotechnologyHealth CareTherapeuticsBiopharmaBiotechnologyHealth CareMedicalPharmaceutical